The Importance of Weight Loss in Obesity

2min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

Drug companies are doing so-called outcomes trials, trying to prove that if you give their drugs to someone who is obese, although you'll reduce the rate of heart attacks and strokes. So they're trying to do that. And those trials should start reading out as soon as this summer,. Those are going to be very, very important to determine what kind of coverage that these drugs get over the long term.

Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements in weight loss treatments–and the fight over who should pay for them. And Dr. Angela Fitch, a physician and president of the Obesity Medical Association, talks about the challenges of treating obesity.

Read their reporting here: Good Luck Paying for Those $10,000 Obesity Drugs Everyone’s Talking About

Listen to The Big Take podcast every weekday and subscribe to our daily newsletter: https://bloom.bg/3F3EJAK

Have questions or comments for Wes and the team? Reach us at bigtake@bloomberg.net.

See omnystudio.com/listener for privacy information.